MHLW’s Feat to Link Drug Review and Reimbursement Policies Put to Test with “Expensive Drugs”

June 28, 2016
The “ sakigake ” pricing premium introduced in April was hailed by the pharma industry as something that would improve predictability, because it links drug reviews and reimbursement prices by giving a premium to products designated under the sakigake fast-track...read more